Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) PT Lowered to $280; RBC Capital: 'Excessive Sell-Off Creates Defensive Opportunity'

October 14, 2026 8:54 AM
RBC Capital analyst Trung Huynh lowered the price target on Johnson & Johnson (NYSE: JNJ) to $280.00 (from $290.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change